Drugs / i-FactorTM Bone graft
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04610021 | Mar 2021 → Mar 2024 overdue | scoliosis | Complejo Asistencial Universitario de León Urgencias | Not yet recruiting | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | i-FactorTM Bone graft | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04610021 ↗ |
| Known as | I-Factor Bone Graft | “I-Factor ™ Bone Graft (Cerapedics, Inc., Westminster, CO) is a compound formed by peptide P-15 bound to an anorganic bone mineral of bovine origin that is composed of porous...” NCT04610021 ↗ |
| Modality | Peptide | “compound formed by peptide P-15 bound to an anorganic bone mineral” NCT04610021 ↗ |